➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Medtronic
Harvard Business School
Baxter
AstraZeneca

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Zonisamide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for zonisamide and what is the scope of patent protection?

Zonisamide is the generic ingredient in two branded drugs marketed by Sunovion Pharms Inc, Ani Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Bionpharma Inc, Celltrion, Epic Pharma Llc, Glenmark Generics, Heritage Pharma, Invagen Pharms, Mylan, Mylan Pharms Inc, Roxane, Sun Pharm Inds (in), Sun Pharm Industries, Upsher Smith Labs, and Zydus Pharms Usa, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for zonisamide. Nineteen suppliers are listed for this compound.

Drug Prices for zonisamide

See drug prices for zonisamide

Drug Sales Revenue Trends for zonisamide

See drug sales revenues for zonisamide

Recent Clinical Trials for zonisamide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rose Research Center, LLCPhase 3
Foundation for a Smoke-Free WorldPhase 3
Ain Shams UniversityN/A

See all zonisamide clinical trials

US Patents and Regulatory Information for zonisamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Celltrion ZONISAMIDE zonisamide CAPSULE;ORAL 077636-001 Dec 22, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Celltrion ZONISAMIDE zonisamide CAPSULE;ORAL 077636-002 Jul 27, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Sunovion Pharms Inc ZONEGRAN zonisamide CAPSULE;ORAL 020789-002 Aug 22, 2003 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Merck
Medtronic
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.